Vertex Pharmaceuticals Just Made a $10 Billion Acquisition Worth Watching
The biotech’s diversification efforts continue.
Memory Chips Just Fell Into a Bear Market. Micron Is Down 30% From Its High Even as AI Demand Booms.
The fundamentals say boom. The stock price says the boom is ending. One of them is wrong.
Anthropic’s Potential $1.2 Trillion IPO Could Make This Stock a Major Beneficiary
Amazon has a large stake in Anthropic.
Oil Pulls the Market Lower Again
Oil may not be the big driver of stocks that it was a few months ago — and the market’s pullback may simply be a healthy breather for hot stocks.
Even With Elon Musk’s SpaceX Stock (SPCX) Down Below Its IPO Price, I’d Still Rather Buy This Dividend Stock in July
Why opt for speculation when you could grab a 6.3% dividend yield that’s been paid for 127 years in a row?
AI Expectations Hit a Fever Pitch
Despite churning out incredible numbers, semiconductor stocks still seem to somehow “miss expectations.” The team digs into Wall Street’s expectations game.
Is It Too Late to Buy Johnson & Johnson After Its Blowout Earnings Report?
J&J has more than 28 sources of blockbuster revenue.
Cathie Wood Is Loading Up on This GLP-1 Stock That Has Soared 1,600% Over the Past 10 Years
Maybe you should, too.